Trial NCT04683484
Publication Nguyen T, medRxiv, 2021
Primary outcome on the report: 1. Vaccine safety; 2. Anti-S IgG antibody response

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.